The use of antimicrobial agents in the aquatic environment would cause concern, in terms of both potential environmental impact and potential human health implications. Both malachite green and Sulphadimethoxine are on the Food and Drug Administration’s priority list for fish drugs that need analytical methods of development (Rushing and Hansen, 1997 and Gehring et al., 2006).